Comparaitive study of the content of plasma atrial natrinretic peptides(ANP),endothelin-1(ET-1) in patients with diabetic nephropathy
Cai Xu
Abstract
Cai Xu
Abstract
Objective To investigate changes in plasma atrial natrinretic peptides(ANP),endothelin-1(ET-1),before and after treatment in patients with diabetic nephropathy(DN).Methods The content of plasma ANP and ET-1 were measured in 43 DN cases and 20 normal control cases using radioimmunoassary.Results The plasma levels of ET-1 and ANP were significantly increased in the patients with DN compared with those in the controls(P0.05).The plasma levels of ET-1 and ANP after treatment were significantly lower than that before therapy.The plasma levels of ET-1 and ANP in treatment group were lower than those in routine group after treatment for 12 months(P0.05).Conclusion The plasma levels of ET-1 and ANP may be related with diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate changes in plasma atrial natrinretic peptides(ANP),endothelin-1(ET-1),before and after treatment in patients with diabetic nephropathy(DN).Methods The content of plasma ANP and ET-1 were measured in 43 DN cases and 20 normal control cases using radioimmunoassary.Results The plasma levels of ET-1 and ANP were significantly increased in the patients with DN compared with those in the controls(P0.05).The plasma levels of ET-1 and ANP after treatment were significantly lower than that before therapy.The plasma levels of ET-1 and ANP in treatment group were lower than those in routine group after treatment for 12 months(P0.05).Conclusion The plasma levels of ET-1 and ANP may be related with diabetic nephropathy.
Key concepts: Medicine, Endothelin receptor, Internal medicine, Atrial natriuretic peptide, Endocrinology, Nephropathy, Diabetic nephropathy, Endothelin 1